3 healthcare shares that I want in my portfolio

CSL Limited (ASX:CSL) shares are one of three that I think investors ought to consider buying in the healthcare sector…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

One area of the market that I'm especially bullish on over the long-term is the healthcare sector.

I believe this area of the market is well positioned to grow strongly over the next decade or two due to growing demand for healthcare services and the emergence of new technologies.

Three healthcare shares that I think could make great long-term investments are as follows:

CSL Limited (ASX: CSL)

CSL Limited is one of the world's leading biopharmaceutical companies. Over the last decade the company has consistently grown its sales and earnings at a strong rate thanks to its core business and ever-expanding portfolio of lucrative products. I don't expect this to change any time soon and believe it would be a fantastic share to buy and hold.

ResMed Inc. (ASX: RMD)

Another top option in the healthcare sector in my opinion is ResMed. It is a medical device company with a focus on the sleep treatment market. Like CSL, it has a long track record of generating solid earnings growth and creating wealth for its shareholders. Pleasingly, due to its leading products, wide distribution, and growing market, I believe the company is well-positioned to continue this trend for a long time to come.

Volpara Health Technologies Ltd (ASX: VHT)

Volpara Health Technologies has been growing at an explosive rate over the last 18 months thanks to its popular breast imaging analytics and analysis software. In its recent half year results management advised that 5.4% of women being screened (2.1 million) in the United States are now being actively analysed by a Volpara product. This is expected to grow to 9% by the end of the financial year. Importantly, with much of its breast imaging analytics data flowing to the cloud, the company now has one of the biggest cross-vendor data sets in mammography. Management believes this is a powerful asset not only for finding key insights to help detect breast cancer early but also for developing new products that can help increase its average price per patient.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended VOLPARA FPO NZ. The Motley Fool Australia has recommended ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

woman talking on the phone and giving financial advice whilst analysing the stock market on the computer with a pen
Growth Shares

2 great ASX shares to buy for 2026: experts

These ASX shares are expected to deliver big returns in 2026…

Read more »

woman looking at iPhone whilst working on a laptop
Growth Shares

3 of the best Australian shares to buy and hold until 2035

It could be worth holding tightly to these shares for the long term.

Read more »

Two large bulls fight against each other in the dust.
Growth Shares

2 quality ASX 200 stocks to buy for your 2026 portfolio

Brokers are bullish on these mainstay sector picks.

Read more »

A woman stands at her desk looking a her phone with a panoramic view of the harbour bridge in the windows behind her with work colleagues in the background.
Growth Shares

Analysts say these ASX 200 shares could rise 30% to 40%

Big returns could be on offer with these growing stocks.

Read more »

Four piles of coins, each getting higher, with trees on them.
Growth Shares

2 ASX 200 shares that could be top buys for growth

These two businesses have an exciting future.

Read more »

Man pointing at a blue rising share price graph.
Growth Shares

The 3 biggest ASX multibaggers in 2025

These billion-dollar ASX companies have delivered eye-catching multibagger returns in 2025.

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Growth Shares

These world class ASX 200 growth shares could rise 40% to 80%

These high-quality shares are seriously undervalued according to brokers.

Read more »

A male ASX investor sits cross-legged with a laptop computer in his lap with a slightly crazed, happy, excited look on his face while next to him a graphic of a rocket shoots upwards with graphics of stars scattered around it
Healthcare Shares

Up 10x since July, could this hot ASX stock be the next Droneshield?

Investors chase asymmetric upside and 4DMedical is one of the ASX's hottest stocks right now.

Read more »